Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load
- PMID: 8786327
Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load
Abstract
Although vigorous activated and memory CTL have been associated with HIV-1 infection, data are lacking regarding the breadth of epitopes recognized in a given individual and the relationship to the viral quasispecies present in vivo. In this study we performed a detailed analysis of the HIV-1-specific CTL response in a seropositive person with documented HIV-1 infection of 15 yr duration, stable CD4 counts above 500 cells/ml, and viral load persistently below 500 molecules of RNA/ml of plasma. Epitope mapping studies revealed the presence of HLA class I-restricted CTL responses to six different epitopes in p17, p24, RT, Env, and Nef, which conferred broadly cross-reactive recognition of reported HIV-1 variants. Sequence analysis of autologous viruses revealed the absence of immune escape variants within five of the six epitopes. Despite consistently low viral RNA levels in plasma and viral DNA levels in PBMC, in vivo-activated circulating CTL were detected against three of the epitopes. Five of the six epitopes, including the three dominant epitopes, have been detected in persons with progressive disease, suggesting that nonprogressors may not target unique epitopes. This study demonstrates that HIV-1-specific CTL can be highly activated and broadly directed in the setting of an extremely low viral load, and that neither high viral load nor antigenic diversity is required for the generation of a multispecific CTL response. Although the detection of strong CTL responses, low viral load, and lack of immune escape are consistent with the hypothesis that CTL may contribute to lack of disease progression in this individual, the contribution of these responses to maintenance of the asymptomatic state remains to be determined.
Similar articles
-
Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.J Immunol. 1998 Nov 1;161(9):4875-81. J Immunol. 1998. PMID: 9794421
-
Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.J Immunol. 1996 Nov 1;157(9):4212-21. J Immunol. 1996. PMID: 8892659
-
Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.AIDS. 2008 Jul 11;22(11):1277-86. doi: 10.1097/QAD.0b013e3283021a8c. AIDS. 2008. PMID: 18580606
-
Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.Clin Sci (Lond). 1999 Dec;97(6):707-18. Clin Sci (Lond). 1999. PMID: 10585898 Review.
-
The cytotoxic T-lymphocyte response in HIV-1 infection.Clin Lab Med. 1994 Jun;14(2):271-99. Clin Lab Med. 1994. PMID: 7924192 Review.
Cited by
-
The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.Eur J Immunol. 2015 Aug;45(8):2232-42. doi: 10.1002/eji.201545451. Epub 2015 Jun 24. Eur J Immunol. 2015. PMID: 26018465 Free PMC article.
-
HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.Blood. 2006 Dec 1;108(12):3808-17. doi: 10.1182/blood-2006-05-021576. Epub 2006 Aug 10. Blood. 2006. PMID: 16902147 Free PMC article. Clinical Trial.
-
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.J Clin Invest. 1997 Sep 15;100(6):1581-9. doi: 10.1172/JCI119682. J Clin Invest. 1997. PMID: 9294127 Free PMC article.
-
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.J Virol. 1999 Jul;73(7):5509-19. doi: 10.1128/JVI.73.7.5509-5519.1999. J Virol. 1999. PMID: 10364299 Free PMC article.
-
Moringa supplementation improves immunological indices and hematological abnormalities in seropositive patients receiving HAARTs.Afr Health Sci. 2022 Jun;22(2):1-11. doi: 10.4314/ahs.v22i2.2. Afr Health Sci. 2022. PMID: 36407401 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials